Effects of Exendin-4 on Glucose Metabolism and Pdx-1 Mrna Expression in OLETF Rat

ZHU Min,SHI Hong-li,FANG Jing-chong,LIU Yu,LU Bin,ZHU Xi-xing

DOI: https://doi.org/10.3760/j:issn:0254-9026.2005.12.012

2005-01-01

Abstract:Objective To observe the effects of glucagon-like peptide-1 agonist exendin-4 on glucose and insulin level and the expression of transcription factor pdx-1 mRNA in diabetic animal model OLETF rat with genetic insulin resistance. Methods OLETF rats randomly divided into 4 groups: vehicle(control),exendin-4 doses of 5 μg/kg(EX4 A),20 μg/kg(EX4 B)、 100 μg/kg(EX4 C).The exendin-4 was injected daily.Oral glucose tolerance test and insulin release test were performed after 7 days treatment.The pdx-1 mRNA expression was detected by RT-PCR.Results Glucose tolerance was improved in EX4 groups,fasting and postprandial glucose and peak glucose levels were significantly lower and insulin secret was statistically increased than in control group,P0.05.The HOMA-B in EX4 groups(98.18±29.14,73.74±22.19,135.86±58.62 respectively)were also improved, much higher than that of 36.88±15.14 in control group,P0.05.While HOMA-IR were not significantly different in statistics among EX4 A,EX4 B and control groups.The expressions of pdx-1 mRNA in three EX4 groups were 0.40±0.15,0.56±0.15 and 0.65±0.1,notably elevated than 0.24±0.13 in control group,P0.05.Conclusions The exendin-4 treatment enhances insulin secret,decreases glucose level,improves glucose tolerance and B-cell function,and up-regulates the pdx-1 mRNA expression in OLETF rat.